| Literature DB >> 36099933 |
Xianhui Liu1,2, Joanna C Chiu1.
Abstract
O-linked-N-acetylglucosaminylation (O-GlcNAcylation) is a nutrient-sensitive protein modification that alters the structure and function of a wide range of proteins involved in diverse cellular processes. Similar to phosphorylation, another protein modification that targets serine and threonine residues, O-GlcNAcylation occupancy on cellular proteins exhibits daily rhythmicity and has been shown to play critical roles in regulating daily rhythms in biology by modifying circadian clock proteins and downstream effectors. We recently reported that daily rhythm in global O-GlcNAcylation observed in Drosophila tissues is regulated via the integration of circadian and metabolic signals. Significantly, mistimed feeding, which disrupts coordination of these signals, is sufficient to dampen daily O-GlcNAcylation rhythm and is predicted to negatively impact animal biological rhythms and health span. In this review, we provide an overview of published and potential mechanisms by which metabolic and circadian signals regulate hexosamine biosynthetic pathway metabolites and enzymes, as well as O-GlcNAc processing enzymes to shape daily O-GlcNAcylation rhythms. We also discuss the significance of functional interactions between O-GlcNAcylation and other post-translational modifications in regulating biological rhythms. Finally, we highlight organ/tissue-specific cellular processes and molecular pathways that could be modulated by rhythmic O-GlcNAcylation to regulate time-of-day-specific biology.Entities:
Keywords: O-GlcNAcylation rhythm; biological rhythms; circadian input; hexosamine biosynthetic pathway; metabolic input; phosphorylation
Mesh:
Substances:
Year: 2022 PMID: 36099933 PMCID: PMC9470261 DOI: 10.1098/rsob.220215
Source DB: PubMed Journal: Open Biol ISSN: 2046-2441 Impact factor: 7.124
Figure 1Schematic illustrating metabolic and circadian regulation of rhythmic protein O-linked-N-acetylglucosaminylation (O-GlcNAcylation). The circadian clock oscillator receives environmental signals and regulates daily feeding–fasting cycles. Feeding–fasting cycles rhythmically provide input to hexosamine biosynthetic pathway (HBP), which contributes to rhythmic production of UDP-GlcNAc [15]. O-GlcNAc transferase (OGT) takes UDP-GlcNAc as a substrate and transfers GlcNAc onto serine and threonine residues of proteins. This process is recognized as O-GlcNAcylation (O-GlcNAc is depicted as G on protein molecules). Metabolic input can also regulate the O-GlcNAcylation rhythm through modifying the activities of glutamine:fructose-6-phosphate amidotransferase (GFAT) [37–49], OGT [21,50–63] and O-GlcNAcase (OGA) [64]. Additionally, the clock oscillator not only regulates feeding–fasting cycles, but also regulates the expression or enzymatic activities of all the HBP enzymes [39,47,65–76] and O-GlcNAc processing enzymes [62,63,71,72,77–93]. The potential mediating factors of metabolic and circadian inputs are illustrated in the schematic diagram; metabolic inputs are depicted in brown and circadian inputs are depicted in blue. The dashed arrows indicate potential regulation without known mechanisms. HK, Hexokinase; GPI, phosphoglucose isomerase; GFAT, glutamine–fructose-6-phosphate aminotransferase; GNPNAT, glucosamine-phosphate N-acetyltransferase; PGM3, phosphoacetylglucosamine mutase; UAP1, UDP-N-acetyl glucosamine pyrophosphorylase 1; OGT, O-GlcNAc transferase; OGA, O-GlcNAcase; Glc, glucose; Glc-6-P, glucose-6-phosphate; Fruc-6-P, fructose-6-phosphate; GlcN-6-P, glucosamine-6-phosphate; GlcNAc-6-P, N-acetylglucosamine-6-phosphate; GlcNAc-1-P, N-acetylglucosamine-1-phosphate; UTP , uridine triphosphate; UDP-GlcNAc, uridine diphosphate N-acetylglucosamine; mTOR, mammalian target of rapamycin; NR4A1, nuclear subfamily 4 group A member 1; GCN2, general control nonderepressible2; miRNA, microRNA; AMPK, AMP-activated protein kinase; EGF, epidermal growth factor; TGFβ, transforming growth factorβ; Sp1, specificity protein 1; PKA, protein kinase A; Nrf2, nuclear factor E2-related factor-2; E2F1, transcription factor E2F1; HNF1A, hepatocyte nuclear factor 1 homologue A; LSD2, lysine-specific histone demethylase 1B; E6AP, ubiquitin ligase E6AP; ChK1, checkpoint kinase 1; ROCK2, Rho-associated coiled-coil forming protein kinase 2; MYPT1, myosin phosphatase target subunit 1.
Figure 2Daily rhythmicity of the O-GlcNAcome can integrate metabolic and circadian signals to modulate rhythmicity of the phosphoproteome. O-GlcNAcylation can modulate rhythmic activities of ‘circadian kinases’, which have been previously identified by analysing circadian/daily phosphoproteomic datasets [25,27]. We define this as enzyme level regulation. For substrate level regulation, O-GlcNAcylation can directly compete with phosphorylation by targeting the same residue on substrate proteins and/or modulate the protein conformation to promote or inhibit phosphorylation by targeting an approximal site [129–133]. Independently, phosphorylation is also sensitive to environmental and metabolic signals. In sum, interplay between daily phosphorylation and O-GlcNAcylation regulates time-of-day functions of cellular proteins and daily physiological rhythms. GSK3β, Glycogen synthase kinase3β; S6K1, ribosomal protein S6 kinase 1; AMPK, AMP-activated protein kinase; PKC, protein kinase C; MAPK p38, mitogen-activated protein kinase p38, ERK1/2, extracellular signal-regulated kinase1/2; CK2α casein kinase2α.
O-GlcNAcylation of kinases known to regulate circadian rhythm. GSK3β, glycogen synthase kinase3β; S6K1, ribosomal protein S6 kinase 1; AMPK, AMP-activated protein kinase; PKC, protein kinase C; MAPK p38, mitogen-activated protein kinase p38; ERK1/2, extracellular signal-regulated kinase1/2, CK2α casein kinase2α.
| kinases | O-GlcNAc sites | function of O-GlcNAcylation | references |
|---|---|---|---|
| AKT | T308, S473 (characterized by mutagenesis) | inhibit AKT phosphorylation at T308 and S473, and inhibit AKT activity | [ |
| GSK3 | n.a. | promote GSK3 | [ |
| S6K1 | S489 (characterized by mutagenesis) | inhibit S6K1 phosphorylation at S418 and T229, and inhibit S6K1 activity | [ |
| AMPK | n.a. | inhibit AMPK | [ |
| PKC | T408, T410 (characterized by mutagenesis) | inhibit PKC | [ |
| MAPK p38 | n.a. | promote p38 phosphorylation, and activate p38 activity | [ |
| ERK1/2 | n.a. | promote ERK1/2 phosphorylation, and activate ERK1/2 activity | [ |
| CK2 | S347 (validated by Edman sequencing) | inhibit CK2 | [ |
Figure 3O-GlcNAcylation regulates daily biological rhythms from cellular to organismal level. O-GlcNAcylation rhythmically modifies circadian clock proteins, key components of the molecular oscillator [21–23]. Global increase in cellular O-GlcNAcylation slows down the pace of circadian clocks, which in turn alters timing of rhythmic cellular processes [20–22]. In addition to clock proteins, thousands of other cellular proteins are also O-GlcNAcylated. O-GlcNAcylation is directly involved in regulating basic cellular functions, such as transcriptional regulation, RNA metabolism, translation, protein metabolism [16–19]. Furthermore, O-GlcNAcylation can also modify activities of organ-, tissue- or cell-specific processes [153–173]. In summary, rhythmic O-GlcNAcylation ranging from subcellular to organ levels manifest into robust daily biological rhythms at the organismal level. dCLK, Drosophila CLOCK; dCYC Drosophila CYCLE; BMAL1, brain and muscle Arnt-like protein-1; CLOCK, circadian locomotor output cycles kaput; dPER, Drosophila PERIOD; dTIM, Drosophila TIMELESS; PER1-3, PERIOD1-3; CRY1-2, CRYPTOCHROME1-2.
O-GlcNAcomic studies in animal tissues and cell lines.
| tissue or cell type | organism | number of O-GlcNAc proteins | number of O-GlcNAc sites | tissue- or cell-specific function of O-GlcNAcylation | references |
|---|---|---|---|---|---|
| forebrain | rat | 25 | n.a. | cellular communication/signal transduction; intracellular transport | [ |
| hippocampus | mouse | 14 | n.a. | neuronal structure; glucose metabolism | [ |
| cerebral cortical tissue | mouse | 274 | n.a. | neurogenesis; synaptic transmission; learning and memory; cytoskeleton | [ |
| cortex | mouse | 278 | n.a. | synaptic trafficking; notch/Wnt signalling; circadian clock proteins | [ |
| brain | rat | 30 | n.a. | signal transduction; cytoskeleton and vesicle trafficking | [ |
| brain | human | 530 | 1094 | receptor signalling; substrate-adhesion dependent cell spreading; cell projection assembly | [ |
| gastrocnemius muscle | rat | 14 | n.a. | glycolytic pathway and energetic metabolism; contractile protein | [ |
| C2C12 myotubes | mouse | 342 | n.a. | cytoskeleton and chaperones; transporter and binding proteins; cell adhesion molecules | [ |
| right ventricle | rat | 500 | n.a. | oxidation–reduction process; intracellular transport; metabolism; cellular respiration and energy | [ |
| embryonic kidney cells (HEK293) | human | 1500 | 180 | cell death; molecular transport; cellular assembly and organization; cell cycle, growth and proliferation; cell morphology; PTM | [ |
| embryonic kidney cells (HEK293) | human | 75 | n.a. | cell-cell adhesion; cell cycle; molecular transport; Purine ribonucleoside monophosphate biosynthetic process; cellular response to heat; viral process | [ |
| embryonic kidney cells (HEK293) | human | 215 | n.a. | Metabolism; Signal transduction; Translation; Transport | [ |
| urine | human | 457 | n.a. | organelle organization; cell cycle; cellular localization; heterocycle metabolic processes; DNA repair; cellular response to stress; developmental processes; transport | [ |
| T cell | mouse | 116 | n.a. | metabolic process; cellular component organization/biogenesis; DNA packing | [ |
| T cell | human | 133 | n.a. | nucleotide, nucleic acid transport | [ |
| T cell | human | 1045 | n.a. | viral process; cell-cell adhesion; cell cycle; cellular transport; protein sumoylation | [ |
| embryonic macrophage-like cells (S2 cells) | fruit fly | 51 | n.a. | metabolism; stress response; cell cycle | [ |
| liver | rat | 68 | n.a. | metabolism; transport; signal transduction | [ |
| osteoblasts (MC3T3E1) | mouse | 20 | n.a. | post-translational regulation; systemic nutrient homeostasis | [ |
| placental trophoblasts (BeWo) | human | 829 | n.a. | translational initiation; viral transcription; SRP-dependent co-translational protein targeting to membrane | [ |
| fibroblasts (NIH3T3) | mouse | 374 | n.a. | metabolism; intracellular transport | [ |